Cybin (HELP) Retained Earnings (2021 - 2026)
Cybin (HELP) posted quarterly Retained Earnings of $630000.0 for Q1 2026, up 100.27% year-on-year from $314581.0 in Q1 2025, and up 100.21% on a QoQ basis from -$299.9 million in Q3 2025.
Cybin (HELP) Retained Earnings (2021 - 2026) Analysis & Trends
Cybin (HELP) has reported Retained Earnings for 6 consecutive years, with $630000.0 the latest figure, recorded in Q1 2026.
- Quarterly Retained Earnings rose 100.27% year-over-year to $630000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $630000.0 (up 100.27% YoY) and the FY2026 annual result came in at $630000.0, up 100.25% from the prior year.
- Retained Earnings advanced to $630000.0 in Q1 2026 per HELP's latest filing, from -$299.9 million in the prior quarter.
- Over the last five years, Retained Earnings for HELP reached as high as $630000.0 in Q1 2026 and fell as low as -$299.9 million in Q3 2025.
- A 5-year average of -$158.7 million and a median of -$159.2 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 82.67% — and 2026, when it surged 100.27%.
- Year by year, Retained Earnings stood at -$99.0 million in 2022, then tumbled by 51.96% to -$150.5 million in 2023, then sank by 46.88% to -$221.0 million in 2024, then sank by 35.66% to -$299.9 million in 2025, then soared by 100.21% to $630000.0 in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $630000.0, -$299.9 million, and -$266.2 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | 630,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 630,000.00 |
| Sep 30, 2025 | -299.87 Mn |
| Jun 30, 2025 | -266.15 Mn |
| Mar 31, 2025 | -236.51 Mn |
| Dec 31, 2024 | -221.05 Mn |
| Sep 30, 2024 | -218.63 Mn |
| Jun 30, 2024 | -176.25 Mn |
| Mar 31, 2024 | -167.89 Mn |
| Dec 31, 2023 | -150.50 Mn |
| Sep 30, 2023 | -130.21 Mn |
| Jun 30, 2023 | -121.10 Mn |
| Feb 28, 2023 | -40.52 Mn |
| Dec 31, 2022 | -99.04 Mn |
| Sep 30, 2022 | -94.84 Mn |
| Dec 31, 2021 | -65.50 Mn |
| Sep 30, 2021 | -51.92 Mn |
| Jun 30, 2021 | -38.84 Mn |
| Mar 31, 2021 | 18,962.38 |